These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19652233)

  • 1. Usage of a fixed dose of radioactive iodine for the treatment of hyperthyroidism: one-year outcome in a regional hospital in Hong Kong.
    Yau JS; Chu KS; Li JK; Chan KW; Lau IT; Yum SW; Chan CW; Mo LK; Kwan WK
    Hong Kong Med J; 2009 Aug; 15(4):267-73. PubMed ID: 19652233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial to evaluate the effectiveness of 2 regimens of fixed iodine (¹³¹I) doses for Graves disease treatment.
    Santos RB; Romaldini JH; Ward LS
    Clin Nucl Med; 2012 Mar; 37(3):241-4. PubMed ID: 22310249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term follow-up of treated hyperthyroid and hypothyroid patients.
    Leese GP; Jung RT; Scott A; Waugh N; Browning MC
    Health Bull (Edinb); 1993 May; 51(3):177-83. PubMed ID: 8325778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioactive iodine in the treatment of Graves' disease.
    Al-Kaabi JM; Hussein SS; Bukheit CS; Woodhouse NJ; Elshafie OT; Bererhi H
    Saudi Med J; 2002 Sep; 23(9):1049-53. PubMed ID: 12370710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed dose (555 MBq; 15 mCi) radioiodine for the treatment of hyperthyroidism: outcome and its predictors.
    Gupta SK; McGrath S; Rogers K; Attia J; Lewis G; Viswanathan S; Saul M; Allen L
    Intern Med J; 2010 Dec; 40(12):854-7. PubMed ID: 21199224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: the Gateshead Protocol.
    Razvi S; Basu A; McIntyre EA; Wahid ST; Bartholomew PH; Weaver JU;
    Nucl Med Commun; 2004 Jul; 25(7):675-82. PubMed ID: 15208494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine treatment of 524 cats with hyperthyroidism.
    Peterson ME; Becker DV
    J Am Vet Med Assoc; 1995 Dec; 207(11):1422-8. PubMed ID: 7493869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of low doses of radioiodine in the treatment of autonomous thyroid nodules: importance of dose/area ratio.
    Estour B; Millot L; Vergely N; Clavier A; Dhondt O; Caillot A; Brulport V; Descousus M; Dubois F
    Thyroid; 1997 Jun; 7(3):357-61. PubMed ID: 9226203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.
    Chouhan A; Abhyankar A; Basu S
    Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of low-dose radioactive iodine without a thionamide in the treatment of thyrotoxicosis.
    Aitken M; George A; Bodmer C; Cameron J
    Clin Med (Lond); 2003; 3(3):265-7. PubMed ID: 12848263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of hypothyroidism after radioactive iodine therapy for thyrotoxicosis in Hong Kong Chinese.
    Best JD; Chan V; Khoo R; Teng CS; Wang C; Yeung RT
    Clin Radiol; 1981 Jan; 32(1):57-61. PubMed ID: 7214823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.